Anzalone Christopher Richard

Anzalone Christopher Richard is listed in filings as Chief Executive Officer at Arrowhead Pharmaceuticals Inc. This profile follows SEC Form 4 activity through Jan 5, 2026, including sale activity. Recent filings connect the profile to Arrowhead Pharmaceuticals Inc (ARWR). The current snapshot covers public activity from Dec 20, 2024 to Jan 5, 2026. Reported amounts are shown as $488.6K to $2.4M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.